MARKET

VIVO

VIVO

Meridian Biosci
NASDAQ

Real-time Quotes | Nasdaq Last Sale

17.76
+0.44
+2.54%
After Hours: 17.90 +0.14 +0.79% 19:17 11/25 EST
OPEN
17.39
PREV CLOSE
17.32
HIGH
17.85
LOW
17.32
VOLUME
419.13K
TURNOVER
--
52 WEEK HIGH
26.58
52 WEEK LOW
5.51
MARKET CAP
765.03M
P/E (TTM)
17.50
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Meridian Bioscience Participates in Piper Sandler 32nd Annual Virtual Healthcare Conference
CINCINNATI, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today its participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief Financial Officer pre-recorded a fireside chat on Tuesday, November 17, 2020. To register for access to the pre-recorded fireside chat, go to the Events & Presentations section of the Company’s Investor Relations website at https://investor.meridianbioscience.com/ and follow the link provided for the event. The recording will be available until February 15, 2021.About Meridian Bioscience, Inc. Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com.Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: mbi@meridianbioscience.com
GlobeNewswire · 3d ago
Zacks.com featured highlights include: Vista Outdoor, Meridian Bioscience, Standard Motor Products, NIC and Azure Power
Zacks.com featured highlights include: Vista Outdoor, Meridian Bioscience, Standard Motor Products, NIC and Azure Power
Zacks · 6d ago
New Strong Buy Stocks For November 18th
New Strong Buy Stocks For November 18th
Zacks · 11/18 16:25
Has Meridian Bioscience (VIVO) Outpaced Other Medical Stocks This Year?
Is (VIVO) Outperforming Other Medical Stocks This Year?
Zacks · 11/17 16:30
Meridian Bioscience to Participate in Canaccord Genuity Virtual MedTech & Diagnostics Forum
CINCINNATI, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today that Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief Financial Officer, will participate in a live stream fireside chat at the Canaccord Genuity Virtual MedTech & Diagnostics Forum on Thursday, November 19, 2020 at 12:30pm ET.To access the live stream, go to the Events & Presentations section of the Company’s Investor Relations website at https://investor.meridianbioscience.com/. Participants should register several minutes in advance of the event’s start time by following the link provided for the event. A webcast recording will be available for a year following the conclusion of the live event.About Meridian Bioscience, Inc. Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com.Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: mbi@meridianbioscience.com
GlobeNewswire · 11/16 17:00
Should Weakness in Meridian Bioscience, Inc.'s (NASDAQ:VIVO) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
It is hard to get excited after looking at Meridian Bioscience's (NASDAQ:VIVO) recent performance, when its stock has...
Simply Wall St. · 11/16 16:55
Meridian Bioscience (VIVO) Q4 Earnings and Revenues Top Estimates
Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 35.71% and 7.88%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 11/13 15:10
Meridian Bioscience +14% after solid Q4 records top-line growth of 26% and bottom-line growth of 59%; provides FY21 outlook
Meridian Bioscience ([[VIVO]] +13.7%) Q4 results:Revenues: $64.2M (+26.0%); Life Science: $34.4M (+97.0%); Diagnostics $29.8M (-11.0%).Net Income: $6.5M (+58.5%); EPS: $0.15 (+50.0%); non-GAAP Net Income: $8.3M (+53.7%); non-GAAP EPS: $0.19 (+46.2%).Cash
Seekingalpha · 11/13 14:48
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of VIVO. Analyze the recent business situations of Meridian Biosci through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average VIVO stock price target is 25.58 with a high estimate of 30.00 and a low estimate of 20.75.
EPS
Institutional Holdings
Institutions: 298
Institutional Holdings: 45.28M
% Owned: 105.12%
Shares Outstanding: 43.08M
TypeInstitutionsShares
Increased
63
2.20M
New
67
53.45K
Decreased
58
2.72M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.64%
Healthcare Equipment & Supplies
-0.25%
Key Executives
Chairman/Independent Director
David Phillips
Chief Executive Officer/Director
John Kenny
Chief Financial Officer/Senior Vice President/Chief Accounting Officer/Controller/Treasurer
Bryan Baldasare
Executive Vice President
Lourdes Weltzien
Independent Director
James Anderson
Independent Director
Anthony Bihl
Independent Director
Dwight Ellingwood
Independent Director
John McIlwraith
Independent Director
John Rice
Independent Director
Catherine Sazdanoff
Independent Director
Felicia Williams
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
01/22/2019
Dividend USD 0.125
02/01/2019
11/07/2018
Dividend USD 0.125
11/16/2018
07/24/2018
Dividend USD 0.125
08/09/2018
04/25/2018
Dividend USD 0.125
05/04/2018
01/24/2018
Dividend USD 0.125
02/02/2018
11/08/2017
Dividend USD 0.125
11/17/2017
07/25/2017
Dividend USD 0.125
08/03/2017
04/25/2017
Dividend USD 0.125
05/04/2017
01/25/2017
Dividend USD 0.125
02/02/2017
11/09/2016
Dividend USD 0.2
11/17/2016
07/26/2016
Dividend USD 0.2
08/04/2016
04/26/2016
Dividend USD 0.2
05/05/2016
01/26/2016
Dividend USD 0.2
02/04/2016
11/04/2015
Dividend USD 0.2
11/12/2015
07/21/2015
Dividend USD 0.2
07/30/2015
04/21/2015
Dividend USD 0.2
04/30/2015
01/21/2015
Dividend USD 0.2
01/29/2015
11/05/2014
Dividend USD 0.2
11/13/2014
07/22/2014
Dividend USD 0.2
07/31/2014
04/22/2014
Dividend USD 0.2
05/01/2014
01/21/2014
Dividend USD 0.2
01/30/2014
11/06/2013
Dividend USD 0.19
11/14/2013
07/24/2013
Dividend USD 0.19
08/01/2013
04/24/2013
Dividend USD 0.19
05/01/2013
12/04/2012
Dividend USD 0.19
12/12/2012
11/07/2012
Dividend USD 0.19
11/15/2012
07/25/2012
Dividend USD 0.19
08/02/2012
04/25/2012
Dividend USD 0.19
05/02/2012
01/24/2012
Dividend USD 0.19
02/01/2012
11/09/2011
Dividend USD 0.19
11/17/2011
07/20/2011
Dividend USD 0.19
07/28/2011
04/20/2011
Dividend USD 0.19
04/28/2011
01/19/2011
Dividend USD 0.19
01/27/2011
11/10/2010
Dividend USD 0.19
11/18/2010
07/19/2010
Dividend USD 0.19
07/27/2010
04/19/2010
Dividend USD 0.19
04/27/2010
01/20/2010
Dividend USD 0.19
01/28/2010
11/11/2009
Dividend USD 0.17
11/19/2009
07/15/2009
Dividend USD 0.17
07/23/2009
04/15/2009
Dividend USD 0.17
04/22/2009
01/21/2009
Dividend USD 0.17
01/29/2009
11/11/2008
Dividend USD 0.14
11/19/2008
07/16/2008
Dividend USD 0.14
07/28/2008
04/16/2008
Dividend USD 0.14
04/24/2008
01/21/2008
Dividend USD 0.14
01/29/2008
11/13/2007
Dividend USD 0.11
11/21/2007
07/18/2007
Dividend USD 0.11
07/26/2007
04/18/2007
Dividend USD 0.16
04/26/2007
01/18/2007
Dividend USD 0.16
01/25/2007
11/15/2006
Dividend USD 0.115
11/22/2006
More
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About VIVO
Meridian Bioscience, Inc. is a life science company engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels, and the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers. Its segments include Diagnostics and Life Science. The Diagnostics segment includes manufacturing operations in Cincinnati, and the sale and distribution of diagnostic test kits in the countries consisting of North, Central and South America; Europe, the Middle East and Africa (EMEA), and other countries outside of the Americas and EMEA. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; Luckenwalde, Germany, and Sydney, Australia.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Meridian Bioscience, Inc. stock information, including NASDAQ:VIVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VIVO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VIVO stock methods without spending real money on the virtual paper trading platform.